Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
Objective. To evaluate the efficacy of autologous cytokine-induced killer (CIK) cells in patients with renal cell carcinoma (RCC). Methods. 20 patients diagnosed with TNM stage I or II RCC were randomly divided into two groups, a CIK cell treatment group and a control group. The endpoint was progres...
Saved in:
Main Authors: | Yajing Zhang, Jin Wang, Yao Wang, Xue-Chun Lu, Hui Fan, Yang Liu, Yan Zhang, Kai-Chao Feng, Wen-Ying Zhang, Mei-Xia Chen, Xiaobing Fu, Wei-Dong Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/195691 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilization of cardiopulmonary bypass at radical nephrectomy for renal cell carcinoma with tumour thrombus
by: Chalairat Suk‐Ouichai, et al.
Published: (2025-01-01) -
Laparoscopic Radical Nephrectomy: The New Gold Standard Surgical Treatment for Localized Renal Cell Carcinoma
by: Saadettin Yilmaz Eskicorapci, et al.
Published: (2007-01-01) -
Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinoma
by: Jun Ren, et al.
Published: (2024-12-01) -
Risk factors for renal insufficiency and survival implications after radical nephrectomy and thrombectomy in renal cell carcinoma with tumor thrombus: a systematic review
by: Zhigao Huang, et al.
Published: (2025-01-01) -
Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
by: Annika Simone Lück, et al.
Published: (2025-01-01)